Status:
RECRUITING
Validating Immunological Markers Associated With Mental Fatigue in Graves' Disease
Lead Sponsor:
Vastra Gotaland Region
Conditions:
Graves Disease
Mental Fatigue
Eligibility:
All Genders
18-72 years
Brief Summary
Mental fatigue occurs in many diseases and the reasons are mostly unknown. The investigators hypothesize that remaining mental fatigue after restored euthyroidism in Graves' disease is an autoimmune c...
Eligibility Criteria
Inclusion
- Recently diagnosed Graves' disease
- Positive thyroid stimulating hormone (TSH)-receptor antibodies (TRAb)
- Thyroid hormones above the upper reference limit
- Inclusion within three weeks after start of antithyroid drugs
- Controls: Matched for gender and age
Exclusion
- Person unable to follow protocol as with psychosis, dementia or not able to answer questionnaires in Swedish.
- Recidive of Graves' disease
- Pregnancy
- Controls: -Thyroid disease
- Neurological disease
Key Trial Info
Start Date :
September 12 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 20 2025
Estimated Enrollment :
430 Patients enrolled
Trial Details
Trial ID
NCT06081439
Start Date
September 12 2019
End Date
December 20 2025
Last Update
November 18 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Endokrina Forskningsenheten, Sahlgrenska University Hospital
Gothenburg, Sweden, 41346